Reduction-responsive dithiomaleimide-based nanomedicine with high drug loading and FRET-indicated drug release

Hua Wang; Ming Xu; Menghua Xiong; Jianjun Cheng

doi:10.1039/c5cc00148j

Reduction-responsive dithiomaleimide-based nanomedicine with high drug loading and FRET-indicated drug release

Hua Wang, Ming Xu, Menghua Xiong, Jianjun Cheng

Research output: Contribution to journal › Article › peer-review

Abstract

Dithiomaleimide-based camptothecin-containing nanoparticles are designed to have exceptionally high drug loading and are capable of reduction-responsive, FRET-indicated drug release.

Original language	English (US)
Pages (from-to)	4807-4810
Number of pages	4
Journal	Chemical Communications
Volume	51
Issue number	23
DOIs	https://doi.org/10.1039/c5cc00148j
State	Published - Mar 21 2015

ASJC Scopus subject areas

Electronic, Optical and Magnetic Materials
General Chemistry
Ceramics and Composites
Metals and Alloys
Materials Chemistry
Surfaces, Coatings and Films
Catalysis

Online availability

10.1039/c5cc00148j

Library availability

Discover UIUC Full Text

Cite this

@article{69de0ea4f8f54e779206beaffab014ba,

title = "Reduction-responsive dithiomaleimide-based nanomedicine with high drug loading and FRET-indicated drug release",

abstract = "Dithiomaleimide-based camptothecin-containing nanoparticles are designed to have exceptionally high drug loading and are capable of reduction-responsive, FRET-indicated drug release.",

author = "Hua Wang and Ming Xu and Menghua Xiong and Jianjun Cheng",

note = "Publisher Copyright: {\textcopyright} The Royal Society of Chemistry.",

year = "2015",

month = mar,

day = "21",

doi = "10.1039/c5cc00148j",

language = "English (US)",

volume = "51",

pages = "4807--4810",

journal = "Chemical Communications",

issn = "1359-7345",

publisher = "Royal Society of Chemistry",

number = "23",

}

TY - JOUR

T1 - Reduction-responsive dithiomaleimide-based nanomedicine with high drug loading and FRET-indicated drug release

AU - Wang, Hua

AU - Xu, Ming

AU - Xiong, Menghua

AU - Cheng, Jianjun

N1 - Publisher Copyright: © The Royal Society of Chemistry.

PY - 2015/3/21

Y1 - 2015/3/21

N2 - Dithiomaleimide-based camptothecin-containing nanoparticles are designed to have exceptionally high drug loading and are capable of reduction-responsive, FRET-indicated drug release.

AB - Dithiomaleimide-based camptothecin-containing nanoparticles are designed to have exceptionally high drug loading and are capable of reduction-responsive, FRET-indicated drug release.

UR - http://www.scopus.com/inward/record.url?scp=84924370898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924370898&partnerID=8YFLogxK

U2 - 10.1039/c5cc00148j

DO - 10.1039/c5cc00148j

M3 - Article

C2 - 25692778

AN - SCOPUS:84924370898

SN - 1359-7345

VL - 51

SP - 4807

EP - 4810

JO - Chemical Communications

JF - Chemical Communications

IS - 23

ER -

Reduction-responsive dithiomaleimide-based nanomedicine with high drug loading and FRET-indicated drug release

Abstract

ASJC Scopus subject areas

Online availability

Library availability

Related links

Fingerprint

Cite this